[HTML][HTML] Current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients
DV Parums - … science monitor: international medical journal of …, 2022 - ncbi.nlm.nih.gov
On 4 th November 2021, the first oral antiviral drug for COVID-19, molnupiravir (Lagevrio®),
received full regulatory approval from the Medicines and Healthcare Products Regulatory …
received full regulatory approval from the Medicines and Healthcare Products Regulatory …
[HTML][HTML] The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
R Abdelnabi, CS Foo, SJF Kaptein, X Zhang… - …, 2021 - thelancet.com
Abstract Background Favipiravir and Molnupiravir, orally available antivirals, have been
reported to exert antiviral activity against SARS-CoV-2. First efficacy data have been recently …
reported to exert antiviral activity against SARS-CoV-2. First efficacy data have been recently …
[HTML][HTML] RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
HM Dabbous, MH El-Sayed, G El Assal, H Elghazaly… - Scientific reports, 2021 - nature.com
Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different
viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of …
viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of …
The role of antiviral treatment in the COVID-19 pandemic
TK Burki - The Lancet Respiratory Medicine, 2022 - thelancet.com
On Dec 22, 2021, the US Food and Drug Administration (FDA) issued an emergency use
authorisation for Pfizer's COVID-19 antiviral, Paxlovid. Trial results released by the …
authorisation for Pfizer's COVID-19 antiviral, Paxlovid. Trial results released by the …
[HTML][HTML] Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
HM Dabbous, S Abd-Elsalam, MH El-Sayed… - Archives of …, 2021 - Springer
No specific antiviral drugs have been approved for the treatment of COVID-19. This study
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …